Your browser doesn't support javascript.
loading
The co-evolution of the genome and epigenome in colorectal cancer.
Heide, Timon; Househam, Jacob; Cresswell, George D; Spiteri, Inmaculada; Lynn, Claire; Mossner, Maximilian; Kimberley, Chris; Fernandez-Mateos, Javier; Chen, Bingjie; Zapata, Luis; James, Chela; Barozzi, Iros; Chkhaidze, Ketevan; Nichol, Daniel; Gunasri, Vinaya; Berner, Alison; Schmidt, Melissa; Lakatos, Eszter; Baker, Ann-Marie; Costa, Helena; Mitchinson, Miriam; Piazza, Rocco; Jansen, Marnix; Caravagna, Giulio; Ramazzotti, Daniele; Shibata, Darryl; Bridgewater, John; Rodriguez-Justo, Manuel; Magnani, Luca; Graham, Trevor A; Sottoriva, Andrea.
Afiliação
  • Heide T; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Househam J; Computational Biology Research Centre, Human Technopole, Milan, Italy.
  • Cresswell GD; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Spiteri I; Evolution and Cancer Lab, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Lynn C; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Mossner M; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Kimberley C; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Fernandez-Mateos J; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Chen B; Evolution and Cancer Lab, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Zapata L; Evolution and Cancer Lab, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • James C; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Barozzi I; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Chkhaidze K; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Nichol D; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Gunasri V; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Berner A; Centre for Cancer Research, Medical University of Vienna, Vienna, Austria.
  • Schmidt M; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Lakatos E; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Baker AM; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Costa H; Evolution and Cancer Lab, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Mitchinson M; Evolution and Cancer Lab, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Piazza R; Evolution and Cancer Lab, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Jansen M; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Caravagna G; Evolution and Cancer Lab, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Ramazzotti D; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
  • Shibata D; Evolution and Cancer Lab, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Bridgewater J; Department of Pathology, UCL Cancer Institute, University College London, London, UK.
  • Rodriguez-Justo M; Department of Pathology, UCL Cancer Institute, University College London, London, UK.
  • Magnani L; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
  • Graham TA; Department of Pathology, UCL Cancer Institute, University College London, London, UK.
  • Sottoriva A; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
Nature ; 611(7937): 733-743, 2022 11.
Article em En | MEDLINE | ID: mdl-36289335
Colorectal malignancies are a leading cause of cancer-related death1 and have undergone extensive genomic study2,3. However, DNA mutations alone do not fully explain malignant transformation4-7. Here we investigate the co-evolution of the genome and epigenome of colorectal tumours at single-clone resolution using spatial multi-omic profiling of individual glands. We collected 1,370 samples from 30 primary cancers and 8 concomitant adenomas and generated 1,207 chromatin accessibility profiles, 527 whole genomes and 297 whole transcriptomes. We found positive selection for DNA mutations in chromatin modifier genes and recurrent somatic chromatin accessibility alterations, including in regulatory regions of cancer driver genes that were otherwise devoid of genetic mutations. Genome-wide alterations in accessibility for transcription factor binding involved CTCF, downregulation of interferon and increased accessibility for SOX and HOX transcription factor families, suggesting the involvement of developmental genes during tumourigenesis. Somatic chromatin accessibility alterations were heritable and distinguished adenomas from cancers. Mutational signature analysis showed that the epigenome in turn influences the accumulation of DNA mutations. This study provides a map of genetic and epigenetic tumour heterogeneity, with fundamental implications for understanding colorectal cancer biology.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Genoma Humano / Epigenoma / Mutação Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Genoma Humano / Epigenoma / Mutação Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article